Cold Chain: The Coronavirus Vaccine Is Here, Now the Race Is on for More Glass and Ice

Cold Chain: The Coronavirus Vaccine Is Here, Now the Race Is on for More Glass and Ice

Bookmark and Share


SMITH BRAIN TRUST – Though creating a COVID-19 vaccine in record time was a breakthrough, the next step, distribution, will place extraordinary demand on key raw materials – specifically dry ice – and distribution channels. "There are always shortages. You always over-forecast, under-forecast, under-procure, over-procure. This is the nature of supply chains,” Maryland Smith supply chain expert and research professor Sandor Boyson says in a recent Washington Post video story, “The Coronavirus Vaccine Is Here. Now the Race Is on for More Glass and Ice.

The vaccine developed by Pfizer Inc. and partner BioNTech SE must stay extremely cold. between -112° and -76°F. Its shipping and storage require a supply chain, as the video narration describes “like a vaccine conveyor belt stretching from plants to planes to the place of injection for nearly 300 million Americans… Any kinks in this chain could slow down everything.”

The concept of getting vaccines to clinics is nothing new, but volume and urgency make the COVID vaccine supply chain an extraordinary challenge, says Boyson, who has written “Vaccine Supply Chain: Federal Government Must Pivot from Venture Capital Seeder to Overseer” at The Hill. “Everbody’s trying to ramp up, scale up, and pivot. And it’s going to take time. And it’s going to be very sloppy. And it’s not going to be precise.”

Recent national media headlines have reflected Boyson’s point:

As Ultra-Cold Pfizer Vaccines Ship Out, Dry Ice Supplies Tighten in Northeast” – Marketplace Radio

U.S. Quarantines Pfizer Vaccine Shipments in California and Alabama After Transit ‘Anomaly’ Left Vials Too Cold” - CNBC

Pfizer Decision To Turn Off Temperature Sensors Forced Scramble To Ensure COVID-19 Vaccines Kept Ultra-Cold” - STAT

While the Pfizer vaccine requires special, ultracold freezers, the subsequent COVID vaccine produced by Moderna requires shipping and storage at -4°F making it storable in conventional refrigerator-freezers at clinics and pharmacies. “But a limited supply of both vaccines in the initial rollout means that the vaccine available is the one that distribution centers will get,” Boyson says.

Boyson, who more broadly assessed the national vaccine supply chain last month via Smith Brain Trust, says in the Washington Post video: “I’m still not sure… In my gut, I’m not sure we have that command and control, that intelligence in the network to be able to effectively allocate and distribute to all the parts of the country that we really need it to go to right now.”

 

December 23, 2020


Prev   Next



Current Headlines

University of Maryland Research Enterprise Ranked Among Top 10 Publics in NSF Higher Education R&D Survey

Chemistry and Biochemistry Researcher Tiwary Receives NSF CAREER Award

State Must Boost Affordable Housing, UMD Report Finds

CGS Joins Launch of New America Is All In Coalition

Groth Wins NSF CAREER Award

UMD Research Sheds Light on Holiday Travel and COVID

Regional Quantum Research Body Adds Industry, Government, Higher Ed Partners

UMD Driskell Center and iSchool Launch New Crowdsourcing Project to Preserve the Work of African American Art Pioneer

News Resources

Return to Newsroom

Search News

Archived News

Events Resources

Events Calendar

Additional Resources

UM Newsdesk

Faculty Experts

Connect

social iconsFacebookTwitterLinkedInResearch News RSS Feed
Office of Technology Commercialization
2130 Mitchell Building
7999 Regents Dr.
University of Maryland
College Park, MD 20742

Phone: 301-405-3947  |  Fax: 301-314-9502
Email: umdtechtransfer@umd.edu

© Copyright 2013 University of Maryland

Did You Know

UMD's Neutral Buoyancy Research Facility, which simulates weightlessness, is one of only two such facilities in the U.S.